TITLE

Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma

AUTHOR(S)
Wallin, A; Sandström, T; Rosenhall, L; Melander, B
PUB. DATE
June 1993
SOURCE
Thorax;Jun1993, Vol. 48 Issue 6, p611
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66055175

 

Related Articles

  • Budesonide/Formoterol: A Review of its Use in Asthma. Goldsmith, David R.; Keating, Gillian M. // Drugs;2004, Vol. 64 Issue 14, p1597 

    Budesonide and formoterol have been combined in a single dry powder device, Symbicort® Turbuhaler® (budesonide/formoterol 160/9–640/18 µg/day), in an effort to simplify asthma management. The efficacy of budesonide/formoterol as maintenance therapy in patients with asthma has...

  • Bronchodilator effect of single-dose formoterol administered by pressurized metered-dose inhaler in children with asthma aged 6 to <12 years receiving budesonide. Berger, William E.; Gillen, Michael; Eckerwall, Göran; Uryniak, Tom; Trudo, Frank J.; Lampl, Kathy L. // Allergy & Asthma Proceedings;Mar/Apr2014, Vol. 35 Issue 2, p134 

    Dose-response of formoterol via pressurized metered-dose inhaler (pMDI) has not been determined in asthmatic pediatric patients aged 6 to <12 years. This study was designed to assess the bronchodilating dose-response of three formoterol pMDI doses in children with stable asthma aged 6 to <12...

  • Role of new therapies in optimizing asthma care. Bostock-Cox, Beverley // Practice Nursing;Dec2014, Vol. 25 Issue 12, p596 

    The article looks at the new anti-asthma drugs and devices available to treat asthma and the key principles of asthma management. These include fluticasone furoate plus vilanterol, or Relvar, in an Ellipta dry powder inhaler, beclometasone plus formoterol, or Fostair, in a Nexthaler dry powder...

  • Salmeterol vs. Formoterol: A Comparison of Rapid Bronchodilator Effect in a Randomized Controlled Trial. Singhania, Namrata; Dhamija, Radhika; Lodha, R.; Kabra, S. K. // Indian Pediatrics;Mar2008, Vol. 45 Issue 3, p225 

    We conducted this double blind randomized controlled trial to compare the rapid bronchodilator effect of salmeterol and formoterol in 60 children with stable asthma. Participants were randomized to receive either salmeterol (50 µg) (n=31) or formoterol (24 µg) (n=29) by metered dose...

  • Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma. Pauwels, Romain A.; Löfdahl, Claes-Göran; Postma, Dirkje S.; Tattersfield, Anne E.; O'Byrne, Paul; Barnes, Peter J.; Ullman, Anders // New England Journal of Medicine;11/13/97, Vol. 337 Issue 20, p1405 

    Background: The role of long-acting, inhaled β2-agonists in treating asthma is uncertain. In a double-blind study, we evaluated the effects of adding inhaled formoterol to both lower and higher doses of the inhaled glucocorticoid budesonide. Methods: After a four-week run-in period of...

  • Efficacy and Safety of Budesonide and Formoterol in One Pressurised Metered-Dose Inhaler in Adults and Adolescents with Moderate to Severe Asthma. Noonan, Michael; Rosenwasser, Lanny J.; Martin, Paula; O'Brien, Christopher D.; O'Dowd, Liza // Drugs;2006, Vol. 66 Issue 17, p2235 

    Background: Inhaled corticosteroids (ICSs) are the preferred maintenance therapy for adults and children with mild, moderate and severe persistent asthma, with the addition of a long-acting β2-adrenoceptor agonist to ICS therapy recommended for patients with moderate or severe persistent...

  • Budesonide/formoterol pressurized metered-dose inhaler for patients with persistent asthma. Korenblat, Phillip E.; Rosenwasser, Lanny J. // Allergy & Asthma Proceedings;May/Jun2010, Vol. 31 Issue 3, p190 

    The combination of budesonide and formoterol administered in one hydrofluoroalkane pressurized metered-dose inhaler (pMDI) is approved in the United States in two dosage strengths (budesonide/formoterol pMDI 80/4.5 μg × 2 inhalations [160/9 μg] or 160/4.5 μg × 2 inhalations...

  • Clinic Roundup.  // BioWorld Today;6/7/2013, Vol. 24 Issue 109, p7 

    This article presents updates on clinical trials of biopharmaceutical companies as of June 7, 2013. Alexion Pharmaceuticals of Connecticut reported that chronic therapy with Soliris (eculizumab) was effective for hemolytic uremic syndrome. BioLineRx of Jerusalem enrolled its first patient in a...

  • Aclidinium bromide/formoterol fumarate dry-powder inhaler: a guide to its use in chronic obstructive pulmonary disease in the EU. Lyseng-Williamson, Katherine // Drugs & Therapy Perspectives;Jun2015, Vol. 31 Issue 6, p183 

    The use of a dry-powder inhaler containing both aclidinium bromide (a long-acting antimuscarinic agent) and formoterol fumarate (a long-acting β-selective adrenoreceptor agonist) [Duaklir Genuair] is an effective, convenient and well-tolerated option for the maintenance treatment of adults...

  • FORMOTEROL -- UNIKALNY β2-MIMETYK O SZYBKIM I DŁUGOTRWAŁYM DZIAŁANIU PODAWANY ZA POMOCÄ„ INHALATORA SUCHEGO PROSZKU (AEROLIZER) -- OXODIL FIRMY POLPHARMA S.A. POLIWCZAK, ADAM RAFAŁ; BAŁA, AGNIESZKA; KOZIRÓG, MARZENA; ZABIELSKA, JUSTYNA; BRONCEL, MARLENA // Problemy Terapii Monitorowanej;sep2008, Vol. 19 Issue 3, p251 

    Inhalatory β2-mimetics are one of the most potent drugs used in obturative lung diseases. At first they were administered by nebulisators, than by Meterd Dose Inhalers -- MDI, currently they are delivered in form of dry powder by Dry Powder Inhalers --DPI. Formoterol is β2-mimetic drug...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics